Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
Volberding PA, Lagakos SW, Grimes JM, Stein DS, Rooney J, Meng TC, Fischl MA, Collier AC, Phair JP, Hirsch MS, et al. Volberding PA, et al. Among authors: stein ds. N Engl J Med. 1995 Aug 17;333(7):401-7. doi: 10.1056/NEJM199508173330701. N Engl J Med. 1995. PMID: 7616988 Free article. Clinical Trial.
Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group.
Graham NM, Hoover DR, Park LP, Stein DS, Phair JP, Mellors JW, Detels R, Saah AJ. Graham NM, et al. Among authors: stein ds. Ann Intern Med. 1996 Jun 15;124(12):1031-8. doi: 10.7326/0003-4819-124-12-199606150-00002. Ann Intern Med. 1996. PMID: 8633816 Clinical Trial.
Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobulin. Multicenter AIDS Cohort Study.
Stein DS, Lyles RH, Graham NM, Tassoni CJ, Margolick JB, Phair JP, Rinaldo C, Detels R, Saah A, Bilello J. Stein DS, et al. J Infect Dis. 1997 Nov;176(5):1161-7. doi: 10.1086/514108. J Infect Dis. 1997. PMID: 9359714
Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.
Saravolatz LD, Winslow DL, Collins G, Hodges JS, Pettinelli C, Stein DS, Markowitz N, Reves R, Loveless MO, Crane L, Thompson M, Abrams D. Saravolatz LD, et al. Among authors: stein ds. N Engl J Med. 1996 Oct 10;335(15):1099-106. doi: 10.1056/NEJM199610103351503. N Engl J Med. 1996. PMID: 8813040 Free article. Clinical Trial.
Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team.
Schooley RT, Campbell TB, Kuritzkes DR, Blaschke T, Stein DS, Rosandich ME, Phair J, Pottage JC, Messari F, Collier A, Kahn J. Schooley RT, et al. Among authors: stein ds. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):363-70. doi: 10.1097/00042560-199608010-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8673545 Clinical Trial.
141 results